Antimicrobial | MSSA (N = 86) | MRSA (N = 37) | ||||||
---|---|---|---|---|---|---|---|---|
MIC range | MIC50 | MIC90 | Non-susceptiblea isolates (%) | MIC range | MIC50 | MIC90 | Non-susceptiblea isolates (%) | |
Oxacillin | 0.25–2 | 1 | 2 | 0 | 16 to ≥ 256 | 256 | ≥ 256 | 100b |
Vancomycin | 0.5–2 | 2 | 2 | 0 | 0.5–2 | 2 | 2 | 0 |
Teicoplanin | 0.25–2 | 0.5 | 1 | 0 | 0.25–1 | 0.5 | 0.5 | 0 |
Linezolid | 0.25–1 | 1 | 1 | 0 | 0.25–2 | 0.5 | 1 | 0 |
Daptomycin | 0.5–2 | 1 | 2 | 13.9 | 0.5–2 | 1 | 2 | 13.5 |
Ceftaroline | NA | NA | NA | NA | 0.25–0.75 | 0.5 | 0.75 | 0 |